Quarterly Result
| Symbiotec Pharmalab Ltd Industry: (Pharmaceuticals - Indian - Bulk Drugs & Formln) |
|---|
|
BSE Code:
544889
ISIN Demat:
INE899I01028
Book Value(₹): 195.23 NSE Symbol:
SYMBIOTEC
Div & Yield(%):
N.A
Market Cap(₹ Cr): 7,935.95 P/E(TTM):
50.91
EPS(TTM):
24.26
Face Value(₹): 2.00 |
| Particulars | Jun 2026 (₹ Cr) | Mar 2026 (₹ Cr) | Jun 2025 (₹ Cr) |
|---|---|---|---|
| Gross Sales | 210.84 | 213.08 | 204.26 |
| Excise Duty | 0.00 | 0.00 | 0.00 |
| Net Sales | 210.84 | 213.08 | 204.26 |
| Other Operating Income | 0.00 | 0.00 | 0.00 |
| Other Income | 19.55 | 18.68 | 11.47 |
| Total Income | 230.39 | 231.75 | 215.74 |
| Total Expenditure | 151.60 | 216.95 | 141.92 |
| PBIDT | 78.79 | 14.80 | 73.82 |
| Interest | 5.62 | 6.45 | 5.11 |
| PBDT | 73.17 | 8.35 | 68.71 |
| Depreciation | 10.15 | 11.31 | 9.30 |
| Tax | 16.02 | 13.12 | 16.01 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.01 | -0.39 | -1.11 |
| Reported Profit After Tax | 47.01 | -15.69 | 44.51 |
| Extra-ordinary Items | 0.00 | -39.69 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 47.01 | 24.00 | 44.51 |
| EPS (Unit Curr.) | 7.49 | -2.73 | 8.00 |
| EPS (Adj) (Unit Curr.) | 7.49 | -2.73 | 8.00 |
| Calculated EPS (Unit Curr.) | 7.32 | -2.44 | 6.93 |
| Calculated EPS (Adj) (Unit Curr.) | 7.32 | -2.44 | 6.93 |
| Calculated EPS (Ann.) (Unit Curr.) | 29.26 | -9.77 | 27.71 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 29.26 | -9.77 | 27.71 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 |
| Equity | 12.85 | 12.85 | 12.85 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 37.37 | 6.95 | 36.14 |
| PBDTM(%) | 34.70 | 3.92 | 33.64 |
| PATM(%) | 22.30 | -7.36 | 21.79 |